Prophylactic antibiotic in patients who undergo cystoscopy with urine sterile: a double blind controlled clinical trial
What is the efficacy of antibiotic (levofloxacin) prophylaxis compared with placebo in patients of both genders aged 18 years and above who are undergoing cystoscopy with sterile urine in decreasing the incidence of urinary tract infection?
Herney Garcia
300 participants
Jul 20, 2012
Interventional
Conditions
Summary
There will be a double-blind controlled clinical trial Multicentre, with the aim of providing critical information for making decisions regarding the use of antibiotic prophylaxis in patients who undergo outpatient cystoscopy. It makes the next project is to determine for 2011, the effectiveness of antibiotic prophylaxis in patients with sterile urine, will be to establish the incidence of urinary tract infection in each group as the primary outcome variable and determine the possible complications and effects adverse experimental therapy. Will take care of the proper use of the principles of medical ethics such as: justice, beneficence and respect.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intervention group: Prophylactic antibiotic levofloxacin 500 mg orally single dose 30 to 60 minutes before the cystoscopy
Locations(2)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000750987